424 related articles for article (PubMed ID: 15044555)
1. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
Bermack JE; Haddjeri N; Debonnel G
J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555
[TBL] [Abstract][Full Text] [Related]
2. Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors.
Bermack JE; Debonnel G
J Psychopharmacol; 2007 Jan; 21(1):85-92. PubMed ID: 16533864
[TBL] [Abstract][Full Text] [Related]
3. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
Jordan S; Chen R; Koprivica V; Hamilton R; Whitehead RE; Tottori K; Kikuchi T
Eur J Pharmacol; 2005 Jul; 517(3):165-73. PubMed ID: 15985260
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA
J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523.
Tottori K; Miwa T; Uwahodo Y; Yamada S; Nakai M; Oshiro Y; Kikuchi T; Altar CA
Neuropharmacology; 2001 Dec; 41(8):976-88. PubMed ID: 11747902
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
van Amsterdam C; Seyfried CA
Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
[TBL] [Abstract][Full Text] [Related]
7. 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.
Froger N; Gardier AM; Moratalla R; Alberti I; Lena I; Boni C; De Felipe C; Rupniak NM; Hunt SP; Jacquot C; Hamon M; Lanfumey L
J Neurosci; 2001 Oct; 21(20):8188-97. PubMed ID: 11588191
[TBL] [Abstract][Full Text] [Related]
8. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y
Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the potent 5-HT(1A/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant/anxiolytic efficacy.
Watson JM; Dawson LA
CNS Drug Rev; 2007; 13(2):206-23. PubMed ID: 17627673
[TBL] [Abstract][Full Text] [Related]
10. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
[TBL] [Abstract][Full Text] [Related]
11. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.
Hajós M; Hajós-Korcsok E; Sharp T
Br J Pharmacol; 1999 Apr; 126(8):1741-50. PubMed ID: 10372816
[TBL] [Abstract][Full Text] [Related]
12. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological evidence for rapid 5-HT₁A autoreceptor inhibition by vilazodone, a 5-HT₁A receptor partial agonist and 5-HT reuptake inhibitor.
Ashby CR; Kehne JH; Bartoszyk GD; Renda MJ; Athanasiou M; Pierz KA; Seyfried CA
Eur J Pharmacol; 2013 Aug; 714(1-3):359-65. PubMed ID: 23872377
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
Tordera RM; Monge A; Del Río J; Lasheras B
Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
[TBL] [Abstract][Full Text] [Related]
15. Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.
Lladó-Pelfort L; Assié MB; Newman-Tancredi A; Artigas F; Celada P
Br J Pharmacol; 2010 Aug; 160(8):1929-40. PubMed ID: 20649591
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; De Montigny C; Blier P
Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
[TBL] [Abstract][Full Text] [Related]
17. In vivo electrophysiological assessment of the putative antidepressant Wf-516 in the rat raphe dorsalis, locus coeruleus and hippocampus.
El Mansari M; Blier P
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jan; 376(5):351-61. PubMed ID: 18060386
[TBL] [Abstract][Full Text] [Related]
18. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
Béïque JC; de Montigny C; Blier P; Debonnel G
Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
[TBL] [Abstract][Full Text] [Related]
19. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus.
Haddjeri N; Lavoie N; Blier P
Neuropsychopharmacology; 2004 Oct; 29(10):1800-6. PubMed ID: 15127086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]